肺心宝胶囊对肺心病缓解期临床疗效的影响

Feixinbao Capsule and Observed the Effects in Treating Patient with Chronic Pulmonary Heart Disease in Remission Phase

[目的]研究肺心宝胶囊对肺源性心脏病缓解期临床疗效的影响。[方法]选择40例肺源性心脏病缓解期患者,随机分为两组,治疗组在西医常规治疗的基础上同时予肺心宝胶囊口服,对照组予西医常规治疗。治疗1个疗程后,观察比较两组的临床疗效和两组治疗前后临床症状和体征、免疫学、营养学等指标的变化。[结果]两组治疗后总有效率比较,治疗组优于对照组,差异有显著性意义(P<0.05);两组治疗后显效率比较,治疗组优于对照组,差异有高度显著性意义(P<0.01)。两组经治疗后免疫学指标均有明显改善,而治疗组与对照组比较除IgM外,其余各项指标均有显著性意义(P<0.05)。两组间营养学指标治疗后比较(P<0.01),提示治疗组营养学指标疗效优于对照组。[结论]肺心宝胶囊对提高机体免疫功能,改善营养状态有一定的疗效。可以改善肺源性心脏病缓解期患者的免疫功能,从而提高了对肺源性心脏病缓解期患者的临床疗效,提高了患者的生活质量和生存期。是治疗肺心病缓解期的有效药物。

[Objective]In the study, we originated feixinbao capsule and observed the effects in treating patient with chronic pulmonary heart disease in remission phase. [ Methods ] Forty patients in remission phase of chronic pulmonate were randomly divided into two groups. The experimental group was treated by Feixinbao in addition to routine western medicine, while the control group was treated only with western medicine. One course later, We observed and compared the clinical symptoms of the two groups and the changes of immunological indices and nutritional indices. [Results]Compared with control group, the experimental group had significantly improved clinical symptoms and nutritional indices. [ Conclusion ] Feixinbao capsule is a promising drug for treatment of chronic pulmonary heart disease in remising phase with beneficial effects on the improvement of clinical symptoms ,immune function and nutritional status,thus prolonging patient's life and improving patient's life quality. Feixinbao capsule is a effective drue for the treatment of patients with chronic pulmonary heart disease in remission phase.